Abstract:The relationship between a drug and its target directly affects its pharmacology and efficacy. Drug-target binding ability and binding stoichiometry are essential characterization data in pharmaceutical research. The c-myb proto-oncogene encodes a crucial transcription factor that is involved in proliferation, differentiation, and maturation during hematopoiesis. Recent studies have found that the human oncogene c-myb is overexpressed in cancer tissues such as colorectal cancer. C-myb has become a potential therapeutic target for colorectal cancer, leukemia, and other cancers. A guanine (G)-rich DNA sequence located in the promoter region of c-myb can be spontaneously folded to form an intra-molecular G-quadruplex (G4) with cationic induction. The specific recognition of small molecules can stabilize this G4 folding, thus regulating the transcription and expression of c-myb. In this study, pressure assisted capillary electrophoresis frontier analysis (PACE-FA) combined with electrospray ionization mass spectrometry (ESI-MS) was used to investigate the interactions between the human c-myb promoter G4 and natural product molecules. In PACE-FA, an external pressure (no more than 13.8 kPa) in the same direction of the migration of the analyte was used in capillary electrophoresis frontier analysis (CE-FA), which greatly sped up the analysis while maintaining the accuracy of the results. Meanwhile, the combination of PACE-FA and ESI-MS could rapidly determine the affinity and stoichiometric relationship between binding molecules and targets. First, the intramolecular parallel-stranded G4 formation of the c-myb promoter sequence in the presence of cations (K+, NH4+) was investigated by circular dichroism (CD) and ESI-MS. Then, ESI-MS was used to rapidly screen the natural products for candidate molecules that bound the target G4 DNA. The binding interactions were measured by mixing the c-myb DNA with each natural product separately in a 1:4 molar ratio, and then directly infusing these mixtures into the ESI-MS system. From the ESI-MS spectra, IRa values calculated from the relative intensities of DNA and its complex ions were used to probe the binding affinities of the natural products. This parameter denotes the relative binding affinity for a small molecule with the G4 DNA. Three natural products were identified through the screen, and their binding affinities to G4 DNA were ranked as follows:pseudolaric acid B > scopolamine butylbromide > nuciferine. Considering that both specific and non-specific binding existed in the solution phase, a free solution method using PACE-FA was developed to further test the binding ability of these products to the c-myb promoter G4 DNA. In the PACE-FA experiments, the pre-equilibrated mixture of the c-myb G4 DNA and the selected ligand was injected into the capillary prior to separation. Upon applying voltage and an external pressure (6.9 kPa) to the capillary, different species of analytes in the sample migrated at their own rates due to their different sizes and charges. The results showed that scopolamine butylbromide could bind specifically to target G4 DNA with 1:1 stoichiometry and a binding constant of 1.18×105 L/mol. Nuciferine's binding to G4 DNA showed a linear increasing trend due to nonspecific binding; thus nuciferine is a nonspecific binder. Although pseudolaric acid B showed high affinity for the c-myb G4 DNA and 1:1 and 1:2 G4-bound complex ions were observed in ESI-MS measurements, the PACE-FA results indicated that pseudolaric acid B did not bind to target G4 DNA in free solution. Therefore, scopolamine butylbromide could be the best candidate to regulate the transcription of the c-myb oncogene, and is expected to be a precursor for anticancer drugs. In this work, PACE-FA has allowed for significant improvements to the conventional CE-FA technique. This combination of PACE-FA and ESI-MS not only reduced the time needed for binding analysis, but also improved the accuracy and specificity of the affinity analysis compared to conventional binding approaches. Furthermore, this combination could be used to screen other targeted drug candidates and to evaluate their interaction mechanisms.

Characterization of Interaction Between Bcl-2 Oncogene Promoter I-Motif DNA and Flavonoids Using Electrospray Ionization Mass Spectrometry and Pressure-Assisted Capillary Electrophoresis Frontal Analysis.

Design, Synthesis, And Interaction Study Of Quinazoline-2(1h)-Thione Derivatives As Novel Potential Bcl-X(L) Inhibitors

Targeting the Allosteric Pathway That Interconnects the Core-Functional Scaffold and the Distal Phosphorylation Sites for Specific Dephosphorylation of Bcl-2

The Formation and Characteristics of the I-Motif Structure Within the Promoter of the C-Myb Proto-Oncogene.

[Determination of the Binding of Natural Products to the Human C-Myb Oncogene Promoter G-quadruplex DNA by Capillary Electrophoresis and Electrospray Ionization Mass Spectrometry].

Spectroscopy Probing of the Formation, Recognition, and Conversion of A G-Quadruplex in the Promoter Region of the Bcl-2 Oncogene

Novel Synthesis of IMC-48 and Affinity Evaluation with Different i-Motif DNA Sequences

Interaction of Individual Structural Domains of hnRNP LL with the BCL2 Promoter i-Motif DNA

Characterizing the consensus residue specificity and surface of BCL-2 binding to BH3 ligands using the Knob-Socket model

A Newly Identified G-quadruplex As a Potential Target Regulating Bcl-2 Expression

Experimental Characterization of the Binding Affinities Between Proapoptotic BH3 Peptides and Antiapoptotic Bcl-2 Proteins

A Proteomic Analysis of Bcl-2 Regulation of Cell Cycle Arrest: Insight into the Mechanisms

Anti-apoptosis Proteins Mcl-1 and Bcl-xL Have Different P53-Binding Profiles.

Discovery of Small-Molecule Inhibitors of Bcl-2 Through Structure-Based Computer Screening.

Structural Basis of the Specificity and Interaction Mechanism of Bmf Binding to Pro-Survival Bcl-2 Family Proteins.

B1-induced Caspase-Independent Apoptosis in MCF-7 Cells is Mediated by Down-Regulation of Bcl-2 Via P53 Binding to P2 Promoter TATA Box

Specific Binding Constant and Stoichiometry Determination in Free Solution by Mass Spectrometry and Capillary Electrophoresis Frontal Analysis

Inhibitory Effect of Bcl-2 on P53-Mediated Transactivation Following Genotoxic Stress

Bcl2'S Flexible Loop Domain Regulates P53 Binding and Survival

Abstract 1710: an Anti-Apoptotic Bcl-2 Family Protein Index Predicts the Response of Leukemic Cells to the Pan-Bcl-2 Inhibitor S1.

Cell Permeable Bcl-2 Binding Peptides: A Chemical Approach to Apoptosis Induction in Tumor Cells